What's Causing This Strange Constellation of Symptoms in an Older Woman? Prompt assessment and treatment needed to prevent blindness, authors warn Aug 08, 2022
FDA OKs First Interchangeable Ranibizumab Biosimilar When available, Cimerli qualifies for pharmacy-level substitution for reference drug Aug 03, 2022
Durable Vision Improvement With Light Therapy for Dry Macular Degeneration Also from ASRS: gene therapy for retinitis pigmentosa, anti-VEGF implant matches injection Jul 20, 2022
Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease Longer treatment-free interval with similar vision outcomes versus aflibercept in neovascular AMD Jul 19, 2022
Intravitreal Methotrexate Reduces Reoperation After Retinal Detachment Repair Reoperation rate reduced by three fourths, use expanded to advanced diabetic retinopathy Jul 18, 2022
Link Between Neovascular Eye Disease, CVD Tracked to Retinal Lesions Subretinal drusenoid deposits found in 85% of patients with AMD and CVD in small study Jul 16, 2022
Gene Therapy Shows Promise for Age-Related Macular Degeneration Reduced treatment burden, durable therapeutic effects with aflibercept-expressing construct Jul 15, 2022
'Senolytic' Therapy Shows Promise in Neovascular Eye Disease Clearing out dying cells, approach has implications far beyond ophthalmology Jul 14, 2022
Primary Care Screening Flops in Detecting Diabetic Eye Disease Fundoscopy screening had low sensitivity, accuracy in primary care setting Jun 28, 2022
Concerning Trends in Vision Impairment for Adults With Diabetes? Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
More Evidence That Fenofibrate Slows Diabetic Eye Disease Significant decline in progression to vision-threatening status, proliferative retinopathy Apr 26, 2022
Vision-Threatening Retinal Condition Linked to COVID-19 Rates of rare retinal vein occlusion jumped after infection, although overall numbers remain low Apr 14, 2022
ED Meds Linked to Higher Risk of Ocular Adverse Events Adjusted incidence rate ratio of 1.85 for three serious conditions with use of PDE5 inhibitors Apr 07, 2022
Diabetic Eye Disease Linked With Neurodegenerative Disorders Future risk of systemic neurodegeneration, particularly cognitive impairment, more than doubled Mar 22, 2022
Are Crossed Eyes a Risk Factor for Mental Illness in Kids? Study showed moderate association between strabismus and some childhood mental health disorders Mar 10, 2022
First Drug-Eluting Contact Lens Wins FDA Nod Contact lens releases antihistamine to treat itchy eyes Mar 03, 2022
Glaucoma Risk Persists Years After Cataract Surgery in Young Children "Lifelong follow-up" is important for these kids Feb 10, 2022
FDA Approves First Generic of Restasis for Dry Eye A new option for those affected by keratoconjunctivitis sicca Feb 02, 2022
Extremely Preterm Babies Have Higher Risk of Eye Problems as Adults Study followed participants for 20 years, though attrition was significant Jan 28, 2022
Type 1 vs Type 2 Youth-Onset Diabetes: Which Is Worse for the Eyes? One type had a higher risk for all diabetes-related ocular complications Dec 02, 2021
Microstent for Cataract Surgery Reduced Need for Glaucoma Meds Device lowers eye pressure by promoting fluid flow through Schlemm's canal Nov 17, 2021
COVID-19 Linked to Long List of Eye Abnormalities Indian eye doctors also warn of dangerous infections associated with steroids, diabetes Nov 16, 2021
Long-Term LASIK Outcomes in Myopia Beat Out Rival SMILE Procedure Results point to effectiveness of LASIK in more challenging cases, researcher says Nov 16, 2021
Patients on New Thyroid Eye Disease Drug Are OK With Ear Problems Few discontinued teprotumumab due to hearing loss, tinnitus Nov 15, 2021
Eye Surgeons Divided Over Same-Day Bilateral Cataract Surgeries New AAO guidelines urge caution, say patients should make final decision Nov 15, 2021
Midlife Women With Declining Eyesight: Are They Also Looking at Future Depression? Varying degrees of visual impairment tied to depressive symptoms Oct 27, 2021
Continuous-Release Anti-VEGF Device for AMD Wins FDA Approval Susvimo ocular implant with 6-month refill proved equivalent to monthly eye injections Oct 23, 2021
C5 Inhibitor Slows Geographic Atrophy in Dry Macular Degeneration Progression slowed by 27-30% at 12 and 18 months with avacincaptad versus sham control Oct 13, 2021
Bispecific Antibody Compares Favorably With Anti-VEGF for Retinal Disease Similar visual acuity and safety with potential for extended dosing interval Oct 13, 2021
Continuous-Release Anti-VEGF for Macular Degeneration Continues to Impress Implant matches monthly injections for efficacy with 6-month refill schedule Oct 13, 2021
Adverse Events Halt Gene Therapy Trial for Diabetic Macular Edema Three cases of irreversible vision loss, high rate of intraocular inflammation Oct 12, 2021
Early Steroid Switch May Improve Visual Acuity for Some DME Patients Significant improvement in vision, retinal thickening after inadequate response to anti-VEGF Oct 11, 2021
Face Masks May Risk Bacterial Spread to Eyes During Intravitreal Injections No clear link to endophthalmitis after ophthalmologic procedure -- yet Oct 10, 2021
Doc Admits to Using Misbranded Eye Medication on Patients James Heroman, MD, also falsely billed Medicare to make a profit, DOJ alleged Oct 07, 2021
When Prior Authorization Practices Go Too Far Congress can reverse a troubling trend that creates patient care disruptions Sep 12, 2021
Baltimore School Vision Program Misses the Mark in Raising Most Test Scores A fleeting reading benefit suggests modifications to the intervention may help, however Sep 10, 2021
Watch for Eye Problems in Kids Born to Mothers With Diabetes Any type of diabetes exposure in utero increased risk for high refractive error Aug 17, 2021
Anti-VEGF Injections Preserved Vision in Severe Diabetic Retinopathy Aflibercept also reduced vision-threatening complications Aug 05, 2021
